Hyundai Pharmaceutical Co., Ltd.
KRX:004310.KS
4735 (KRW) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||||
| Net Income
| 6,621.566 | -164.583 | -3,173.176 | 2,187.064 | 1,212.848 | -2,106.348 | 1,458.347 | 1,260.887 | 1,593.782 | 1,468.256 | 1,459.606 | -4,847.717 | 989.545 | 2,968.064 | 1,670.588 | 3,475.226 | 9,736.198 |
| Depreciation & Amortization
| 3,300.37 | 3,297.26 | 3,978.908 | 4,112.361 | 3,513.2 | 3,199.76 | 2,525.186 | 2,237.537 | 1,964.32 | 1,909.464 | 2,110.718 | 2,357.159 | 2,274.17 | 2,288.775 | 2,604.512 | 2,625.037 | 2,303.304 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -28,231.585 | 1,749.897 | -600.183 | 2,785.059 | -3,043.431 | 1,717.956 | -7,750.742 | -8,402.507 | -5,348.311 | -1,993.417 | 2,463.072 | -1,320.525 | 434.137 | -2,207.995 | -15,017.307 | -12,513.255 | -3,777.99 |
| Accounts Receivables
| 3,000.656 | -840.241 | 1,072.019 | 2,978.366 | -1,434.49 | -331.195 | -4,363.035 | -6,948.44 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| -3,142.76 | -2,366.041 | -4,956.697 | 356.921 | -379.498 | -320.956 | -817.549 | -2,357.036 | -165.341 | 880.006 | 1,977.464 | -8,273.7 | -4,572.267 | 17.308 | -3,671.282 | 701.64 | -1,281.618 |
| Accounts Payables
| -6,202.055 | 1,289.324 | 3,852.098 | 1,156.16 | -1,400.8 | 1,919.368 | 1,192.604 | 2,606.251 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -21,887.426 | 3,666.855 | -567.603 | -1,706.386 | 171.356 | 2,038.912 | -6,933.193 | -6,045.471 | -5,182.97 | -2,873.423 | 485.608 | 6,953.175 | 5,006.404 | -2,225.303 | -11,346.025 | -13,214.895 | -2,496.372 |
| Other Non Cash Items
| 13,764.366 | 6,741.193 | 4,926.66 | 1,719.855 | 4,031.097 | 588.14 | 1,786.005 | 2,157.11 | -1,057.961 | 2,085.828 | 1,917.69 | 1,113.782 | 4,149.647 | -370.61 | 3,853.119 | 5,314.389 | -2,059.148 |
| Operating Cash Flow
| -4,545.283 | 11,623.767 | 5,132.209 | 10,804.339 | 5,713.714 | 3,399.508 | -1,981.203 | -2,746.972 | -2,848.17 | 3,470.132 | 7,951.086 | -2,697.302 | 7,847.499 | 2,678.234 | -6,889.088 | -1,098.603 | 6,202.364 |
| Investing Activities: | |||||||||||||||||
| Investments In Property Plant And Equipment
| -6,104.432 | -6,583.939 | -6,808.867 | -6,400.745 | -2,359.027 | -3,231.415 | -3,103.002 | -3,680.15 | -2,485.346 | -1,248.007 | -2,263.997 | -2,110.125 | -3,778.575 | -4,623.172 | -2,371.678 | -17,609.87 | -14,310.264 |
| Acquisitions Net
| 793.116 | 6.558 | -5,483.404 | -5,788.834 | 4.302 | 1,239.311 | -129.892 | 1,560.617 | 18.238 | 144 | 1,009.017 | 6,639.794 | 1,268.097 | 0 | 1,062.001 | 2,919.073 | 9,382.367 |
| Purchases Of Investments
| -3,977.528 | -3,740.108 | -10,001.7 | -6,489.656 | -373.101 | -3,232.118 | -505.859 | -1,905.886 | -14,022.035 | -7.688 | -204.244 | -448.9 | -13.611 | 0 | -4,241.453 | -805.78 | -25,980.07 |
| Sales Maturities Of Investments
| 4,493.809 | 291.487 | 16,745.682 | 427.263 | -4.302 | 340 | 6,177.12 | 2,779.451 | 10,655.865 | 783 | 723.544 | 72.874 | 30 | 183.698 | 1,184.33 | 10,973.947 | 23,199.59 |
| Other Investing Activites
| 1,706.62 | 35 | 5,520.541 | 5,863.834 | 4.302 | -1,157.811 | 140 | -1,508.589 | 750.188 | 0.62 | 22.663 | 653.264 | -216.634 | 10,354.023 | 1,104.897 | 37.838 | -317.839 |
| Investing Cash Flow
| -3,088.416 | -9,991.002 | -27.748 | -12,388.137 | -2,727.827 | -6,042.033 | 2,578.367 | -2,754.556 | -5,083.089 | -328.075 | -713.017 | 4,806.907 | -2,710.723 | 5,914.549 | -3,261.903 | -4,484.792 | -8,026.216 |
| Financing Activities: | |||||||||||||||||
| Debt Repayment
| -8,000 | -10,000 | -10,000 | -21,000 | -21,000 | -29,453.103 | -26,935.855 | -21,000 | -18,764 | -20,749.88 | -14,536.12 | -7,818.999 | -2,000 | -13,521.671 | -6,790.374 | 0 | 0 |
| Common Stock Issued
| 0 | -10,000 | 0 | 6,526.148 | 0 | 14,594.075 | 29,453.103 | 1,172.383 | 3,369.76 | 0 | 0 | 0 | 0 | 12,000 | 1,470.992 | 0 | 1,632.81 |
| Common Stock Repurchased
| -3,803.529 | -1,526.314 | 0 | -279.304 | -1,710.947 | -3,191.055 | -2,356.477 | -2,236.089 | 0 | 0 | 0 | 0 | 0 | -2,058.009 | -1,476.714 | -11,880.345 | 0 |
| Dividends Paid
| -826.2 | -836.054 | -1,184.412 | -1,214.578 | -1,232.164 | -1,179.525 | -1,145.675 | -1,158.182 | -1,055.706 | -996.799 | -881.701 | -938.606 | -1,055.649 | -1,224.224 | -1,598.881 | -2,103.294 | -2,067.535 |
| Other Financing Activities
| 6,200.702 | 29,367.658 | 14,435.695 | 23,419.355 | 21,000 | 21,000 | 0 | 26,935.855 | 21,000 | 18,764.001 | 6,000 | 9,286 | 0 | -0.001 | 13,202.139 | 16,588.235 | 0 |
| Financing Cash Flow
| -6,429.027 | 7,005.29 | 3,251.284 | 7,451.622 | -2,943.111 | 1,770.393 | -984.904 | 3,713.967 | 4,550.055 | -2,982.678 | -9,417.822 | 528.394 | -3,055.649 | -4,803.905 | 4,807.162 | 2,604.596 | -434.725 |
| Other Information: | |||||||||||||||||
| Effect Of Forex Changes On Cash
| -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -456.018 | 0 | 0 | 0 | 0.001 | -0.001 | 0.001 | 0.001 |
| Net Change In Cash
| -14,062.725 | 8,638.055 | 8,355.745 | 5,867.824 | 42.776 | -872.132 | -387.74 | -1,787.561 | -3,381.205 | -296.639 | -2,179.753 | 2,637.999 | 2,081.127 | 3,788.879 | -5,343.83 | -2,978.798 | -2,258.576 |
| Cash At End Of Period
| 16,203.426 | 30,266.151 | 21,628.096 | 13,272.351 | 7,404.528 | 7,361.752 | 8,233.883 | 8,621.623 | 10,409.185 | 13,790.389 | 14,087.028 | 16,266.781 | 13,400.739 | 11,319.612 | 7,530.733 | 12,874.563 | 15,853.361 |